Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation - Trial NCT01898910
Access comprehensive clinical trial information for NCT01898910 through Pure Global AI's free database. This Phase 2 trial is sponsored by Meshalkin Research Institute of Pathology of Circulation and is currently Completed. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Meshalkin Research Institute of Pathology of Circulation
Timeline & Enrollment
Phase 2
Jun 01, 2012
Jun 01, 2013
Primary Outcome
Freedom of AF or other atrial arrhythmias
Summary
The investigators have conducted a prospective, double-blind, randomized study to assess the
 comparative safety and efficacy of two different strategies, PVI plus Renal Denervation (RD)
 versus PVI plus GP ablation, in patients with atrial fibrillation. Results were assessed
 after follow-up of at least 1 year with the use of an implanted monitoring device (IMD).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01898910
Non-Device Trial